Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for its Third Quarter of FY 2009
LAIYANG, China, May 14 /PRNewswire-Asia/ -- Jiangbo Pharmaceuticals, Inc., (OTC Bulletin Board: JGBO; "Jiangbo" or the "Company") (which recently changed its name from Genesis Pharmaceuticals Enterprises, Inc., OTC Bulletin Board: GNPH), a U.S. pharmaceutical company with its principal operation...
Jiangbo Pharmaceuticals, Inc. to Present at CCG IR's China Rising Conference in New York
LAIYANG, China, May 12 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc., (OTC Bulletin Board: JGBO; "Jiangbo" or the "Company") (which recently changed its name from Genesis Pharmaceuticals Enterprises, Inc.; OTC Bulletin Board: GNPH), a U.S. pharmaceutical company with its princi...
Jiangbo Pharmaceuticals Announces New Ticker (JGBO) and CUSIP
LAIYANG, China, May 12 /PRNewswire-Asia/ -- Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: GNPH) (the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced that its stock will start trading on the Over the Counter Bulletin ...
Genesis Pharmaceuticals Changes its Name to Jiangbo Pharmaceuticals, Inc. to Reflect its Brand Name
LAIYANG, China, April 23 /PRNewswire-Asia/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) (the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has changed its name to "Jiangbo Pharmaceutic...
Genesis Pharmaceuticals Announces the Launch of Three TCM Products
LAIYANG, China, April 22 /PRNewswire-Asia/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced that it began marketing and selling thre...
Genesis Pharmaceuticals Affirms Operating Income Guidance, Adjusts Revenue Guidance for Fiscal 2009
LAIYANG, China, April 2 /PRNewswire-Asia/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today affirmed its previously announced operating income ...
CFO of Genesis Pharmaceuticals Gives Live Interview on Bloomberg TV Asia
LAIYANG, China, March 6 /PRNewswire-Asia-FirstCall/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced that its CFO, Ms Elsa Sung, gav...
Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009
LAIYANG, China, Feb. 17 /PRNewswire-Asia/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) (“Genesis” or the “Company”), a U.S. pharmaceutical company with its principal operations in the People’s Republic of China, today announced its financial results for the second quar...
Genesis Pharmaceuticals Announces Conference Call to Discuss Results for its Second Quarter of FY 2009
LAIYANG, China, Feb. 12 /PRNewswire-Asia/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) (“Genesis” or the “Company”), a U.S. pharmaceutical company with its principal operations in the People’s Republic of China, today announced that the Company will host a conference c...
Genesis Successfully Defends Multi-Million Dollar Arbitration Filed by CRG and CRGP; Related Parties Withdraw Remaining Demands for Arbitration Against Genesis
LAIYANG, China, Feb. 10 /PRNewswire-Asia/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced that the American Arbitration Association...
Genesis Pharmaceuticals Enters Into Agreement to Purchase Hongrui Pharmaceuticals, and Acquire 22 New Traditional Chinese Medicines
LAIYANG, China, Jan. 29 /PRNewswire-Asia / -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced that Laiyang Jiangbo Pharmaceutical Co.,...
Genesis Pharmaceuticals Appoints KPMG to Help Develop a SOX 404 Compliance Program
LAIYANG, China, Jan. 14 /PRNewswire-Asia/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced that it engaged KPMG Huazhen ("KPMG"), a ...
Genesis Pharmaceuticals Plans to Repurchase up to $2 Million Shares
LAIYANG, China, Nov. 17 /Xinhua-PRNewswire-FirstCall/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced that it plans to repurcha...
Genesis Pharmaceuticals Reports Results for the First Quarter of its Fiscal Year 2009
LAIYANG, China, Nov. 17 /Xinhua-PRNewswire-FirstCall/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced its financial results for...
Genesis Pharmaceuticals Announces Conference Call to Discuss Results for the First Quarter of Fiscal Year 2009
LAIYANG, China, Nov. 13 /Xinhua-PRNewswire/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced that the Company will host a conferen...
Genesis Pharmaceuticals Launches New Corporate Website
LAIYANG, China, Nov. 3 /Xinhua-PRNewswire/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced the launch of its new corporate website ...
Genesis Pharmaceuticals Files Counter Claims
LAIYANG, China, Nov. 01 /Xinhua-PRNewswire/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, was granted leave by the American Arbitration Associati...
Genesis Pharmaceuticals Reports Results for its Fourth Quarter and Fiscal Year 2008
LAIYANG, China, Sept. 30 /Xinhua-PRNewswire/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People’s Republic of China, today announced its financial results for its fourth q...
Genesis Pharmaceuticals Announces Conference Call to Discuss Results for its Fiscal Year 2008
LAIYANG, China, Sept. 29 /Xinhua-PRNewswire-FirstCall/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced that the Company will host a...
Genesis Pharmaceuticals Received New Purchase Orders Worth $12 Million
LAIYANG, China, Sept. 12 /Xinhua-PRNewswire/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the "Company"), a leading pharmaceutical company in the People’s Republic of China, today announced that the Company received purchase orders for a total value of ...
